Next Article in Journal
Biochemical Evidence of Acute Hormonal Abnormality in Aneurysmal Subarachnoid Hemorrhage: Correlation with Clinical Severity
Previous Article in Journal
Euphorbia tirucalli Latex Ingestion Modifies Heart Function and Increases Myocyte Levels of Oxidative Stress in Normotensive Rats
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Beyond M1/M2: The Pivotal Role of Macrophage Metabolic Reprogramming in Chronic Bone Disease and Targeted Intervention

1
School of Tradional Chinese and Werstern Medicine, Gansu University of Chinese Medicine, Lanzhou 730000, China
2
School of Basic Medicine, Gansu University of Chinese Medicine, Lanzhou 730000, China
3
Clinical College of Chinese Medicine, Gansu University of Chinese Medicine, Lanzhou 730000, China
4
Teaching Experiment Training Center, Gansu University of Chinese Medicine, Lanzhou 730000, China
5
Scientific Research and Experimental Center, Gansu University of Chinese Medicine, Lanzhou 730000, China
6
The National Institute of Dunhuang Medicine, Gansu University of Chinese Medicine, Lanzhou 730000, China
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2026, 27(9), 3731; https://doi.org/10.3390/ijms27093731
Submission received: 11 March 2026 / Revised: 15 April 2026 / Accepted: 20 April 2026 / Published: 22 April 2026

Abstract

The progression of chronic bone diseases is intricately linked to dysregulated macrophage polarisation. However, a comprehensive understanding of the complex interplay between macrophage polarisation and metabolic reprogramming in the context of bone disorders remains elusive. Thus, this review conducted a systematic search of major databases, including PubMed, using combinations of keywords such as “macrophage polarisation,” “immunometabolism,” “metabolic reprogramming,” and “chronic bone diseases” (including “osteoporosis,” “osteoarthritis,” and “periodontitis”). Inclusion criteria prioritised original research published within the last five years to capture recent advances. Diverging from previous reviews constrained by the classical M1/M2 dichotomy, this article aims to delineate the heterogeneity and functional plasticity of macrophages within the bone microenvironment, emphasising metabolic reprogramming as a central mechanism driving the dynamic behaviour of macrophages across various skeletal pathologies. Furthermore, this review highlights the pivotal roles of specific metabolites—such as succinate, itaconate, and citrate—within the osseous microenvironment, underscoring their influence on macrophage phenotypic transitions and the regulation of bone metabolic homeostasis. Finally, this article envisages innovative therapeutic strategies targeting the “metabolism–immunity axis,” encompassing the design of nano-delivery systems to modulate macrophage metabolism, the utilisation of engineered extracellular vesicles, the development of immunometabolism-modulating biomaterials, and the exploration of naturally occurring bioactive molecules. Based on these findings, the present work proposes the “metabolism–immunity–skeleton” axis as a theoretical framework, thereby establishing a robust foundation for the development of precision metabolic immunotherapy tailored to a spectrum of chronic bone diseases.
Keywords: chronic bone diseases; macrophage polarization; immunometabolism; metabolic reprogramming; bone homeostasis chronic bone diseases; macrophage polarization; immunometabolism; metabolic reprogramming; bone homeostasis

Share and Cite

MDPI and ACS Style

Wan, Q.; Fang, Z.; Shi, J.; Jiang, Y.; Jin, H.; Sui, C.; Liu, X.; An, F.; Zhang, Y.; Chen, Z.; et al. Beyond M1/M2: The Pivotal Role of Macrophage Metabolic Reprogramming in Chronic Bone Disease and Targeted Intervention. Int. J. Mol. Sci. 2026, 27, 3731. https://doi.org/10.3390/ijms27093731

AMA Style

Wan Q, Fang Z, Shi J, Jiang Y, Jin H, Sui C, Liu X, An F, Zhang Y, Chen Z, et al. Beyond M1/M2: The Pivotal Role of Macrophage Metabolic Reprogramming in Chronic Bone Disease and Targeted Intervention. International Journal of Molecular Sciences. 2026; 27(9):3731. https://doi.org/10.3390/ijms27093731

Chicago/Turabian Style

Wan, Qiao, Zeling Fang, Jiarong Shi, Yu Jiang, Hua Jin, Chuangwei Sui, Xupeng Liu, Fangyu An, Yanxia Zhang, Zhendong Chen, and et al. 2026. "Beyond M1/M2: The Pivotal Role of Macrophage Metabolic Reprogramming in Chronic Bone Disease and Targeted Intervention" International Journal of Molecular Sciences 27, no. 9: 3731. https://doi.org/10.3390/ijms27093731

APA Style

Wan, Q., Fang, Z., Shi, J., Jiang, Y., Jin, H., Sui, C., Liu, X., An, F., Zhang, Y., Chen, Z., Ding, F., & Yan, C. (2026). Beyond M1/M2: The Pivotal Role of Macrophage Metabolic Reprogramming in Chronic Bone Disease and Targeted Intervention. International Journal of Molecular Sciences, 27(9), 3731. https://doi.org/10.3390/ijms27093731

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop